DSPPea34SYNERGIENCT07429968
Synergy in Mental Health Care: Strengthening Collaborations in a Shared Care System for Child and Adolescent Psychiatry (DSPPea34).
An observational study of DSPPea34 and Young People Aged 6-18, run by University Hospital, Montpellier at 1 site in France.
Trial summary
DSPPea34 (Shared Care Program for Children and Adolescents) is an experimental health program designed to provide rapid, guided care orientation for youth aged 6-18 when a first-line psychological follow-up is considered by a general practitioner or pediatrician. Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- DSPPea34, Young People Aged 6-18, Acute and Mild Psychological Disorders
- What is being tested?
- structured online questionnaire and descriptive analysis of patient characteristics and their care pathways, based on electronic medical records
- How many people
- 30 participants
- Where
- 1 siteFrance
- Study dates
- 1 Mar 2026to 1 Mar 2027
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: the population of this study (participants responding to the DELPHI questionnaire) includes professionals directly in contact with families and young people within the framework of DSPPea34 as well as users of DSPPea34. * the pediatricians or general practitioners who have referred a child or adolescent to the DSPPea34 * the hospital and private psychiatrist doctors who conducted an initial assessment as part of the DSPPea34 * the city psychologists who are partners of the program having followed at least one child or adolescent within the framework of the DSPPea34 * the Coordination Nurse (IDC) of DSPPea34 * users (legal guardians and young beneficiaries of the care pathway of DSPPea34)
Who may be able to join
- the professionals directly in contact with families or young people within the framework of DSPPea34 as well as users of DSPPea34
Who cannot join
None listed.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
France1 site
CHU Montpellier - Réseau DSPPea34 de l'Hérault
Montpellier, Hérault
Diane PURPER OUAKIL, MD PhD
About this study
DSPPea34 (Shared Care Program for Children and Adolescents) is an experimental health program designed to provide rapid, guided care orientation for youth aged 6-18 when a first-line psychological follow-up is considered by a general practitioner or pediatrician. The program links hospital-based services and community providers by offering prompt contact and assessment by a registered nurse and/or psychiatrist, with structured feedback to the referring physician.
Primary objective: To identify facilitators that support the engagement of all professionals involved in the care pathway of children and adolescents with psychological difficulties. Facilitators will be mapped across five stages of the pathway: (1) intake, (2) assessment, (3) orientation/referral, (4) inter-partner collaboration, and (5) discharge from the program. Results will be used to refine DSPPea34 specifications to inform broader implementation.
Read more
Methods and study population (primary objective): A Delphi survey will be conducted with stakeholders directly interacting with families and youth within DSPPea34 (e.g., general practitioners (GP), pediatricians, program clinicians) as well as with program users.
Secondary objectives and data sources: To describe (i) the sociodemographic and clinical characteristics of youth using DSPPea34 services and (ii) their care trajectories using quantitative methods. Data will be extracted from DSPPea34 records via the SPICO coordination file (the tool used to facilitate exchanges between the GP/pediatrician, DSPPea34, and the psychologist in charge of follow-up) and complemented by soliciting longitudinal outcome information from the referring physician based on DSPPea34 follow-up.
Findings from this mixed-methods evaluation are expected to guide the optimization and potential scale-up of the DSPPea34 model.
- Being tested
- structured online questionnaire, descriptive analysis of patient characteristics and their care pathways, based on electronic medical records
- Keywords
- Children/adolescents, Mental disorders, City-hospital care pathway
- Medical subject headings
- Mental Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
structured online questionnaireOther
A structured, online Delphi survey conducted in up to three iterative rounds to co-develop and refine proposals related to the DSPPea34 specifications. Questionnaires are developed by study facilitators based on the initial DSPPea34 specifications and new proposals arising from the interim evaluation.
Content and Response Format:
Each round includes closed-ended items rated on a 9-point Likert scale (1 = strongly disagree; 9 = strongly agree) assessing both the content and the wording of each proposal.
Free-text fields allow participants to provide comments and suggested rewording.
Iterative Adaptation Across Rounds:
Based on prior-round results, items may be revised, added, or removed. Refinements aim to improve clarity and relevance, while preserving traceability of changes.
Consensus Rule (Stopping/Exclusion Criterion for Items):
If an item achieves ≥70% agreement (to retain or to remove the proposal) with concordant votes in both Round 1 and Round 2, the proposal is considered
descriptive analysis of patient characteristics and their care pathways, based on electronic medical recordsOther
Data collected from all users of the DSPPea34 program since its inception (approximately 1,200 cases) will include:
- sociodemographic data (age, gender, living environment (urban, semi-urban, rural)
- diagnosis at the end of the initial psychiatric assessment of the DSPPea34 program
- referring physician
- schooling (grade, mainstream or specialized environment)
- existence of previous psychiatric or psychological follow-up
- referrals by DSPPea34 staff and reasons (without collection of individual data for young people not included in DSPPea34 at the end of the staff meeting)
- referrals at the end of the medical consultation and reasons
- end-of-process referrals.
| Study group | Role | What they receive |
|---|---|---|
| the professionals directly in contact with families and young people within the framework of DSPPea3 | Not described Receives: Other: structured online questionnaire | |
| users of the DSPPea34 | Not described Receives: Other: structured online questionnaire; Other: descriptive analysis of patient characteristics and their care pathways, based on electronic medical records |
What is being measured
The primary outcome is the main question the study is designed to answer.
Highlighting by the DELPHI method of the main facilitators of involvement in the DSPPea34 pathway, from successive rounds of proposal prioritization
These facilitators will be identified at different stages: 1) addressing, 2) evaluation, 3) orientation, 4) collaboration between partners, 5) exit from the device and will allow to evolve the specifications of DSPPea in view of its generalization.
Each round includes closed-ended items rated on a 9-point Likert scale (1 = strongly disagree; 9 = strongly agree) assessing both the content and the wording of each proposal. Free-text fields allow participants to provide comments and suggested rewording. Iterative Adaptation Across Rounds: Based on prior-round results, items may be revised, added, or removed. Refinements aim to improve clarity and relevance, while preserving traceability of changes. Consensus Rule (Stopping/Exclusion Criterion for Items): If an item achieves ≥70% agreement (to retain or to remove the proposal) with concordant votes in both Round 1 and Round 2, the proposal is considered
Measured: 3 months
Secondary outcomes (7)
Clinical Characterization at Baseline
Clinical profile including reason for referral, prior or ongoing mental-health follow-up, and functioning assessment coded as ICD-11 diagnostic categories and Children's Global Assessment
Measured: At program entry (Baseline)
Reason for referral to the program
Proportion of patients according to broad categories of referral reasons Unit of Measure: % of participants.
Measured: Baseline
Number of Requests and Referrals (DSPPea34 vs. Outside DSPPea34)
Count of requests and final referral directions (within DSPPea34 or redirected outside DSPPea34).
Measured: Baseline
Number of Psychiatric Clinical Interviews within DSPPea34
Total number of psychiatric clinical interviews conducted as part of DSPPea34.
Measured: At program entry (intake) to program completion (from 1 month to 12 months)
Number of Joint City-Hospital Follow-Ups
Count of joint follow-up episodes involving community (city) providers and hospital-based teams.
Measured: At program entry (intake) to program completion (from 1 month to 12 months)
Number of Follow-Ups Coordinated by Primary Care
Count of follow-up episodes coordinated by primary care actors (e.g., GP or pediatrician).
Measured: At program entry (intake) to program completion (from 1 month to 12 months)
Youth Status at Program Exit
Disposition at discharge (e.g., type of ongoing follow-up, referral destination) and youth outcome at exit
Measured: At program entry (intake) to program completion (from 1 month to 12 months)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted24 Feb 2026
- Study start1 Mar 2026 (estimated)
- Primary completion1 Mar 2027 (estimated)
- Study completion1 Mar 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for DSPPea34Studies of the same condition, open and under way.
- More trials run by University Hospital, MontpellierThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 30 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University Hospital, Montpellier
- Sponsor type
- University, hospital or other
- Collaborators
- UMR UA11INSERM-UMIDESP Institut Desbrest d'Épidémiologie et de Santé Publique
- Responsible party
- Sponsor
- Investigators
- Diane PURPER OUAKIL, MD PhD, Study director, CHU de Montpellier
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07429968
- Sponsor's protocol ID
- RECHMPL24_0352
- Acronym
- SYNERGIE
- Status last verified
- Feb 2026
- First submitted
- 3 Feb 2026
- Last updated
- 24 Feb 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 24 Feb 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Synergy in Mental Health Care: Strengthening Collaborations in a Shared Care System for Child and Adolescent Psychiatry (DSPPea34).
- ClinicalTrials.gov ID
- NCT07429968
- Acronym / sponsor ID
- SYNERGIE / RECHMPL24_0352
- Keywords
- Children/adolescents, Mental disorders, City-hospital care pathway
- Study type
- Observational
- Recruitment status
- Not yet recruiting
- Enrolment
- 30 participants (estimated)
- Lead sponsor
- University Hospital, MontpellierUniversity, hospital or other
- Collaborators
- UMR UA11INSERM-UMIDESP Institut Desbrest d'Épidémiologie et de Santé Publique
- Study start
- 1 Mar 2026 (estimated)
- Primary completion
- 1 Mar 2027 (estimated)
- Study completion
- 1 Mar 2027 (estimated)
- First posted
- 24 Feb 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
DSPPea34 (Shared Care Program for Children and Adolescents) is an experimental health program designed to provide rapid, guided care orientation for youth aged 6-18 when a first-line psychological follow-up is considered by a general practitioner or pediatrician. The program links hospital-based services and community providers by offering prompt contact and assessment by a registered nurse and/or psychiatrist, with structured feedback to the referring physician.
Primary objective: To identify facilitators that support the engagement of all professionals involved in the care pathway of children and adolescents with psychological difficulties. Facilitators will be mapped across five stages of the pathway: (1) intake, (2) assessment, (3) orientation/referral, (4) inter-partner collaboration, and (5) discharge from the program. Results will be used to refine DSPPea34 specifications to inform broader implementation.
Methods and study population (primary objective): A Delphi survey will be conducted with stakeholders directly interacting with families and youth within DSPPea34 (e.g., general practitioners (GP), pediatricians, program clinicians) as well as with program users.
Secondary objectives and data sources: To describe (i) the sociodemographic and clinical characteristics of youth using DSPPea34 services and (ii) their care trajectories using quantitative methods. Data will be extracted from DSPPea34 records via the SPICO coordination file (the tool used to facilitate exchanges between the GP/pediatrician, DSPPea34, and the psychologist in charge of follow-up) and complemented by soliciting longitudinal outcome information from the referring physician based on DSPPea34 follow-up.
Findings from this mixed-methods evaluation are expected to guide the optimization and potential scale-up of the DSPPea34 model.
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| the professionals directly in contact with families and young people within the framework of DSPPea3 | – | Other: structured online questionnaire |
| users of the DSPPea34 | – | Other: structured online questionnaire, Other: descriptive analysis of patient characteristics and their care pathways, based on electronic medical records |
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- the population of this study (participants responding to the DELPHI questionnaire) includes professionals directly in contact with families and young people within the framework of DSPPea34 as well as users of DSPPea34. * the pediatricians or general practitioners who have referred a child or adolescent to the DSPPea34 * the hospital and private psychiatrist doctors who conducted an initial assessment as part of the DSPPea34 * the city psychologists who are partners of the program having followed at least one child or adolescent within the framework of the DSPPea34 * the Coordination Nurse (IDC) of DSPPea34 * users (legal guardians and young beneficiaries of the care pathway of DSPPea34)
Key inclusion criteria (1 listed)
- the professionals directly in contact with families or young people within the framework of DSPPea34 as well as users of DSPPea34
Key exclusion criteria (0 listed)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| structured online questionnaireA structured, online Delphi survey conducted in up to three iterative rounds to co-develop and refine proposals related to the DSPPea34 specifications. Questionnaires are developed by study facilitators based on the initial DSPPea34 specifications and new proposals arising from the interim evaluation. Content and Response Format: Each round includes closed-ended items rated on a 9-point Likert scale (1 = strongly disagree; 9 = strongly agree) assessing both the content and the wording of each proposal. Free-text fields allow participants to provide comments and suggested rewording. Iterative Adaptation Across Rounds: Based on prior-round results, items may be revised, added, or removed. Refinements aim to improve clarity and relevance, while preserving traceability of changes. Consensus Rule (Stopping/Exclusion Criterion for Items): If an item achieves ≥70% agreement (to retain or to remove the proposal) with concordant votes in both Round 1 and Round 2, the proposal is considered | Other | the professionals directly in contact with families and young people within the framework of DSPPea3, users of the DSPPea34 |
| descriptive analysis of patient characteristics and their care pathways, based on electronic medical recordsData collected from all users of the DSPPea34 program since its inception (approximately 1,200 cases) will include: * sociodemographic data (age, gender, living environment (urban, semi-urban, rural) * diagnosis at the end of the initial psychiatric assessment of the DSPPea34 program * referring physician * schooling (grade, mainstream or specialized environment) * existence of previous psychiatric or psychological follow-up * referrals by DSPPea34 staff and reasons (without collection of individual data for young people not included in DSPPea34 at the end of the staff meeting) * referrals at the end of the medical consultation and reasons * end-of-process referrals. | Other | users of the DSPPea34 |
Primary outcome
Highlighting by the DELPHI method of the main facilitators of involvement in the DSPPea34 pathway, from successive rounds of proposal prioritization
Time frame: 3 months
These facilitators will be identified at different stages: 1) addressing, 2) evaluation, 3) orientation, 4) collaboration between partners, 5) exit from the device and will allow to evolve the specifications of DSPPea in view of its generalization. Each round includes closed-ended items rated on a 9-point Likert scale (1 = strongly disagree; 9 = strongly agree) assessing both the content and the wording of each proposal. Free-text fields allow participants to provide comments and suggested rewording. Iterative Adaptation Across Rounds: Based on prior-round results, items may be revised, added, or removed. Refinements aim to improve clarity and relevance, while preserving traceability of changes. Consensus Rule (Stopping/Exclusion Criterion for Items): If an item achieves ≥70% agreement (to retain or to remove the proposal) with concordant votes in both Round 1 and Round 2, the proposal is considered
7 secondary outcomes
Clinical Characterization at Baseline
Time frame: At program entry (Baseline)
Reason for referral to the program
Time frame: Baseline
Number of Requests and Referrals (DSPPea34 vs. Outside DSPPea34)
Time frame: Baseline
Number of Psychiatric Clinical Interviews within DSPPea34
Time frame: At program entry (intake) to program completion (from 1 month to 12 months)
Number of Joint City-Hospital Follow-Ups
Time frame: At program entry (intake) to program completion (from 1 month to 12 months)
Number of Follow-Ups Coordinated by Primary Care
Time frame: At program entry (intake) to program completion (from 1 month to 12 months)
Youth Status at Program Exit
Time frame: At program entry (intake) to program completion (from 1 month to 12 months)
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 24 Feb 2026.
- Individual participant dataSharing planned: Undecided
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Diane PURPER OUAKIL, MD PhD study director
CHU de Montpellier
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of DSPPea34 and Young People Aged 6-18, run by University Hospital, Montpellier at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 24 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Diane PURPER OUAKIL, MD PhD (04 67 33 60 09 ext. +33, mpea@chu-montpellier.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Highlighting by the DELPHI method of the main facilitators of involvement in the DSPPea34 pathway, from successive rounds of proposal prioritization (time frame: 3 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Feb 2026.